Researchers have discovered a new way certain weight-loss medications affect the brain.

New GLP-1 weight-loss pills from Novo Nordisk and Eli Lilly are likely to boost consumer demand, but employer-sponsored health insurance may not foot the bill.

The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – ...

Jessica Rendall is a reporter with experience covering a variety of health and wellness topics, including chronic disease, infectious disease, telemedicine, mental health and health technology. Carley ...

Glucagon-like peptide-1 (GLP-1) medications are now available as a pill for weight loss, offering another option beyond injections. Like the injections, GLP-1 pills can help regulate your appetite, ...

The market leader in obesity shots, Lilly hasn’t made a major dent in the pill market yet.

Users of the weight-loss injection Wegovy have said they will not be swapping to the pill form of the drug, which is now ...

Shifting from weekly glucagon-like peptide-1 (GLP-1) receptor agonist injections to a daily oral medication may be a game-changer for people looking to lose weight, especially those who feel hesitant ...

A new once-daily weight-loss pill called orforglipron delivered better weight loss and blood sugar improvements than the ...

Pharmacies are already facing huge demand for weight-loss pills as the tablets go on sale for the first time, in a move doctors say will transform access to the drug in the UK. Chemists are bracing ...